Obstructive Airway Diseases: Epidemiology, Etiology, and Therapeutic OptionsAbhijit Ray Lipids: Reservoir of Drug Targets Abhijit Ray and Punit Kumar Srivastava Phospholipase A2 as a Potential Drug Target for Airway Disorders Yoshitaka Taketomi and Makoto Murakami 5-Lipoxygenase Pathway: A Validated Route to Drug Discovery Carlo Pergola and Oliver Werz Leukotriene Receptor Antagonists and FLAP Inhibitors Suman Gupta and Sanjay Malhotra EETs and Oxo-ETE in Airway Diseases Jun Yang, Hua Dong, and Bruce D. Hammock The Eosinophil Chemoattractant 5-Oxo-ETE William S. Powell and Joshua Rokach Cyclooxygenases and Prostaglandin Receptors Jitesh P. Iyer, Jitendra Anant Sattigeri, and Sunanda Ghosh DastidarProresolution Mediators of Inflammation in Airway Diseases: Resolvins Pave New DirectionsBruce D. Levy and Charles N. SerhanPlatelet-Activating Factor Antagonist Therapy for Airway DisordersPunit Kumar Srivastava, Kent E. Pinkerton, and Rishabh DevLysophosphatidic Acid in Airway InflammationYutong Zhao and Viswanathan NatarajanSphingolipids in Airway InflammationSameer Sharma and Carole A. OskeritzianProtein Kinase C Isozymes and Airway InflammationPuneet Chopra, V. Senthil, and Manish DiwanProspects for PI3 Kinase Signaling Inhibition in Obstructive Airway DiseasesKazuhiro Ito and Nicolas Mercado